Navigation Links
Valeant Pharmaceuticals To Syndicate Incremental Loans
Date:9/14/2012

MONTREAL, Sept. 14, 2012 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced plans to syndicate an additional $1,000,000,000 of incremental term B loans under its existing senior secured credit facilities.  The incremental term B loans will be used to provide a portion of the financing for Valeant's anticipated acquisition of all of the outstanding common stock of Medicis Pharmaceutical Corporation (NYSE: MRX). The incremental term B loans will have a seven year term and are expected to have terms that are substantially similar to the Company's existing Term Loan B facility. The incremental term B loans are expected to close in the first half of 2013, concurrent with the closing of the transaction. The Company also intends, subject to market and other conditions, to raise approximately $500,000,000 of unsecured debt for general corporate purposes, including acquisitions.

About Valeant Pharmaceuticals International, Inc.

Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, neurology and branded generics.  More information about Valeant Pharmaceuticals International, Inc. can be found at www.valeant.com.

Forward-looking Statements

This press release may contain forward-looking statements.  Forward-looking statements may be identified by the use of the words "anticipates," "expects," "intends," "plans," "should," "could," "would," "may," "will," "believes," "estimates," "potential," or "continue" and variations or similar expressions. These statements which include statements regarding our plans to syndicate incremental term loans and the proposed terms thereof and our expectation as to when and if the incremental term loan facility will close, are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, but are not limited to, risks and uncertainties discussed in the Company's most recent annual or quarterly report filed with the Securities and Exchange Commission ("SEC") and risks and uncertainties as detailed from time to time in the Company's filings with the SEC and the Canadian Securities Administrators ("CSA"), which factors are incorporated herein by reference. Readers are cautioned not to place undue reliance on any of these forward-looking statements. Valeant undertakes no obligation to update any of these forward-looking statements to reflect events or circumstances after the date of this press release or to reflect actual outcomes.

Contact Information:
Laurie W. Little
949-461-6002
laurie.little@valeant.com

(Logo: http://photos.prnewswire.com/prnh/20101025/LA87217LOGO)


'/>"/>
SOURCE Valeant Pharmaceuticals International, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Valeant Pharmaceuticals Announces Management Change
2. Valeant Pharmaceuticals To Present At UBS Annual Global Life Sciences Conference
3. Valeant Pharmaceuticals International, Inc. Agrees To Acquire Medicis Pharmaceutical Corporation For $44.00 Per Share In Cash
4. Valeant Pharmaceuticals To Announce 2012 Second Quarter Results On August 2, 2012
5. Valeant Pharmaceuticals To Host Investor Day
6. Valeant Pharmaceuticals Reports 2012 First Quarter Financial Results
7. Valeant Pharmaceuticals Agrees To Acquire AcneFree And Certain Assets From University Medical
8. Isis Pharmaceuticals Completes Redemption Of 2 5/8% Convertible Subordinated Notes Due 2027
9. Edison Pharmaceuticals Announces Positive Results of EPI-743 Phase 2A Leigh Syndrome Clinical Trial
10. Gerri Henwood Joins Actinium Pharmaceuticals as Chief Development Officer
11. EMA Grants Orphan Designation to Edison Pharmaceuticals for EPI-743 for Treatment of Leigh Syndrome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2020)... ... March 21, 2020 , ... Since 1988, Gwatney dealerships have ... As concerns heighten over the spread of COVID-19, Gwatney Mazda is pleased to announce ... transportation needs of the Memphis community. , The dealership’s new Home Test Drives ...
(Date:3/20/2020)... ... March 20, 2020 , ... Users who have tested positive for ... a crowd-sourced database of detailed location information, such as a specific building on campus ... or exposure to the virus. The app will also help people to more easily ...
(Date:3/20/2020)... ... 2020 , ... On March 19, 2020 Amramp installed a wheelchair ramp to ... The ramp and platforms helped access the large intake triage trailer in the parking ... install ramps that provide access to medical facilities and individual homes. This service enables ...
Breaking Medicine Technology:
(Date:3/22/2020)... ... 2020 , ... In partnership with UC Health, Cincy Shirts has created a ... first responders. The title comes from the English translation of “Juncta Juvant”, the City ... , Proceeds from the sale of the shirt will benefit the YMCA of Cincinnati ...
(Date:3/20/2020)... ... ... CommunityMed Urgent Care , based in Dallas, has rolled out a virtual waiting ... complete registration paperwork (including the latest COVID screening) provide IDs and insurance cards, get ... clean exam room is ready. All of this is done via text and ...
(Date:3/19/2020)... ... March 19, 2020 , ... Sucheta Kamath, Founder and CEO ... free Student Learning Exercise: ExQ® Superpower Hour. During the recent closure ... to help with the immediate need for activities that can be implemented at ...
(Date:3/16/2020)... ... March 16, 2020 , ... The National ... for Coronavirus SARS-CoV-2 (the virus that causes COVID-19 disease) to NKR’s vast network ... and serves approximately 100 transplant programs throughout the United States. NKR has relied ...
(Date:3/15/2020)... Idaho (PRWEB) , ... March ... ... uncertainty and rising levels of confusing information surrounding the Coronavirus (COVID-19) pandemic, ... bear on the health concerns of businesses and employees. HouseCheck has launched ...
Breaking Medicine News(10 mins):